Changing Provider Behavior in the Context of Chronic Disease Management: Focus on clinical inertia

Annual Review of Pharmacology and Toxicology

Volumn 57, Issue , 2017, Pages 263-283

  Lavoie, Kim L ^a,b   Rash, Joshua A ^a,b   Campbell, Tavis S ^a,b,c  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clinical inertia; Clinical practice guidelines; Diagnostic inertia; Evidence based medicine; Therapeutic inertia

Indexed keywords

ASTHMA; AWARENESS; BEHAVIOR CHANGE; BEHAVIOR THEORY; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL AUDIT; CLINICAL INERTIA; CLINICAL MEDICINE; CLINICAL PRACTICE; COGNITIVE BIAS; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; KNOWLEDGE; LIFESTYLE; PATIENT ATTITUDE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SHARED DECISION MAKING; TREATMENT REFUSAL; CLINICAL DECISION MAKING; DISEASE MANAGEMENT; HEALTH CARE PERSONNEL; PROCEDURES; STANDARDS;

CHRONIC DISEASE; CLINICAL DECISION-MAKING; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HEALTH PERSONNEL; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 85009145050     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-010716-104952     Document Type: Review

References (112)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. 1996. Evidence based medicine: what it is and what it isn't. BMJ 312:71-72
2. RosenbergW, Donald A. 1995. Evidence based medicine: an approach to clinical problem-solving. BMJ 310:1122-26
3. Graham R, Mancher M,Wolman DM, Greenfield S, Steinberg E, eds. 2011. Clinical Practice Guidelines We Can Trust.Washington, DC: Natl. Acad. Press
4. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, et al. 1999. Why don't physicians follow clinical practice guidelines A framework for improvement. JAMA 282:1458-65
5. Carlhed R, Bojestig M, Wallentin L, Lindstrom G, Peterson A, et al. 2006. Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study. Am. Heart J. 152:1175-81
6. Grimshaw JM, Russell IT. 1993. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317-22
7. Lugtenberg M, Burgers JS, Westert GP. 2009. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual. Saf. Health Care 18:385-92
8. Sager HB, Linsel-Nitschke P, Mayer B, Lieb W, Franzel B, et al. 2010. Physicians' perception of guideline-recommended low-density lipoprotein target values: characteristics of misclassified patients. Eur. Heart J. 31:1266-73
9. Balder JW, Scholtens S, de Vries JK, van Schie LM, Boekholdt SM, et al. 2015. Adherence to guidelines to prevent cardiovascular diseases: the LifeLines cohort study. Neth. J. Med. 73:316-23
10. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, et al. 2003. The quality of health care delivered to adults in the United States. N. Engl. J. Med. 348:2635-45
11. O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. 2005. Clinical inertia and outpatient medical errors. In Advances in Patient Safety: From Research to Implementation, Vol. 2: Concepts andMethodology, ed. K Henriksen, JB Battles, ES Marks, DI Lewin, pp. 293-308. Rockville, MD: Agency Healthc. Res. Qual.
12. Grahame-Smith D. 1995. Evidence based medicine: Socratic dissent. BMJ 310:1126-27
13. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, et al. 2001. Clinical inertia. Ann. Intern. Med. 135:825-34
14. Allen JD, Curtiss FR, FairmanKA. 2009. Nonadherence, clinical inertia, or therapeutic inertia J. Manag. Care Pharm. 15:690-95
15. Faria C, Wenzel M, Lee KW, Coderre K, Nichols J, Belletti DA. 2009. A narrative review of clinical inertia: focus on hypertension. J. Am. Soc. Hypertens. 3:267-76
16. Okonofua EC, Simpson KN, Jesri A, Rehman SU,Durkalski VL, Egan BM. 2006. Therapeutic inertia is an impediment to achieving theHealthy People 2010 blood pressure control goals. Hypertension 47:345-51
17. Garfinkel D, Mangin D. 2010. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch. Intern. Med. 170:1648-54
18. Hicks PC, Westfall JM, Van Vorst RF, Bublitz Emsermann C, Dickinson LM, et al. 2006. Action or inaction Decisionmaking in patients with diabetes and elevated blood pressure in primary care. Diabetes Care 29:2580-85
19. Reach G. 2014. Clinical Inertia: A Critique of Medical Reason. New York: Springer
20. Asche C, Bode B, Busk A, Nair S. 2012. The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus. Diabetes Obes. Metab. 14:47-57
21. UK Prospect. Diabetes Study Group. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-53
22. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. 1995. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28:103-17
23. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 2008. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359:1577-89
24. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. 2013. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care 36:3411-17
25. ShahBR, Hux JE, Laupacis A, Zinman B, vanWalraven C. 2005. Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary care physicians Diabetes Care 28:600-6
26. McEwen LN, Bilik D, Johnson SL, Halter JB, Karter AJ, et al. 2009. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care 32:971-76
27. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, et al. 2004. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43:10-17
28. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, et al. 2007. Clinical inertia: a common barrier to changing provider prescribing behavior. Joint Comm. J. Qual. Patient Saf. 33:277-85
29. Pittman DG, Fenton C, Chen W, Haffner S, Pendergrass M. 2012. Relation of statin nonadherence and treatment intensification. Am. J. Cardiol. 110:1459-63
30. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, et al. 2006. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann. Intern. Med. 144:475-84
31. Erzen D, Carriere KC, Dik N, Mustard C, Roos LL, et al. 1997. Income level and asthma prevalence and care patterns. Am. J. Respir. Crit. Care Med. 155:1060-65
32. Habbick BF, Pizzichini MMM, Taylor B, Rennie D, Senthilselvan A, Sears MR. 1999. Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ 160:1824-28
33. Kattan M, Crain EF, Steinbach S, Visness CM, Walter M, et al. 2006. A randomized clinical trial of clinician feedback to improve quality of care for inner-city childrenwith asthma. Pediatrics 117:e1095-103
34. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, et al. 2008. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 372:1065-72
35. Krym VF, Crawford B,MacDonald RD. 2004. Compliance with guidelines for emergency management of asthma in adults: experience at a tertiary care teaching hospital. CJEM 6:321-26
36. Cydulka RK, Tamayo-Sarver JH, Wolf C, Herrick E, Gress S. 2005. Inadequate follow-up controller medications among patients with asthma who visit the emergency department. Ann. Emerg. Med. 46:316-22
37. Ducharme FM, Noya FJ, Allen-Ramey FC, Maiese EM, Gingras J, Blais L. 2012. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Curr. Med. Res. Opin. 28:111-19
38. Lougheed MD, Garvey N, Chapman KR, Cicutto L, Dales R, et al. 2009. Variations and gaps in management of acute asthma in Ontario emergency departments. Chest 135:724-36
39. Br. Thorac. Soc., Scott. Intercoll. Guidel. Netw. 2014. British guideline on the management of asthma. Thorax 69:i1-92
40. Natl. Heart Lung Blood Inst., Natl. Asthma Educ. Prev. Program. 2007. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Rep., Natl. Inst. Health, Bethesda, MD
41. WHO (World Health Organ.). 2013. Burden of COPD. Geneva: WHO. http://www.who.int/respiratory/copd/burden/en/index.html
42. Murphy SL, Kochanek KD, Xu J, Arias E. 2015. Mortality in the United States, 2014. NCHS Data Brief, Natl. Cent. Health Stat., Hyattsville, MD
43. Cooke CE, Sidel M, Belletti DA, Fuhlbrigge AL. 2012. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD 9:73-80
44. Kaminsky DA, Marcy TW, BachandM, Irvin CG. 2005. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir. Care 50:1639-48
45. Glob. Initiat. Chronic Obstr. Lung Dis. 2016. Global strategy for the diagnosis, management, and prevention of COPD. Rep., Glob. Initiat. Chronic Obstr. Lung Dis. (GOLD). http://goldcopd.org/globalstrategy-diagnosis-management-prevention-copd-2016/
46. Diette GB, Orr P, McCormack MC, Gandy W, Hamar B. 2010. Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines Popul. Health Manag. 13:21-26
47. Heins-Nesvold J, Carlson A, King-Schultz L, Joslyn KE. 2008. Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received. Int. J. Chronic Obstr. Pulm. Dis. 3:415-21
48. Barr RG, Celli BR, Martinez FJ, Ries AL, Rennard SI, et al. 2005. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am. J. Med. 118:1415.e9-17
49. Chavez PC, Shokar NK. 2009. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD 6:446-51
50. Aujoulat I, Jacquemin P, Rietzschel E, Scheen A, Trefois P, et al. 2014. Factors associated with clinical inertia: an integrative review. Adv. Med. Educ. Pract. 5:141-47
51. Byrnes PD. 2011. Why haven't I changed that Therapeutic inertia in general practice. Aust. Fam. Phys. 40:24-28
52. Byrne D, O'Connor L, Jennings S, Bennett K, Murphy AW. 2015. A survey of GPs awareness and use of risk assessment tools and cardiovascular disease prevention guidelines. Ir. Med. J. 108:204-7
53. Kiberd J, Panek R, Kiberd B. 2007. Strategies to reduce clinical inertia in hypertensive kidney transplant recipients. BMC Nephrol. 8:10
54. Nicolucci A, Rossi MC. 2008. Incretin-based therapies: a new potential treatment approach to overcome clinical inertia in type 2 diabetes. Acta Biomed. 79:184-91
55. Redon J, Coca A, Lazaro P, Aguilar MD, Cabanas M, et al. 2010. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J. Hypertens. 28:1770-77
56. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, et al. 1998. Inadequate management of blood pressure in a hypertensive population. N. Engl. J. Med. 339:1957-63
57. Nau DP, Mallya U. 2005. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am. J. Manag. Care 11:69-73
58. Howes F, Hansen E,Williams D, Nelson M. 2010. Barriers to diagnosing and managing hypertension: a qualitative study in Australian general practice. Aust. Fam. Phys. 39:511-16
59. Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, et al. 2007. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 30:807-12
60. Reach G. 2008. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 34:382-85
61. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. 2009. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373:929-40
62. Handler J, Lackland DT. 2011. Translation of hypertension treatment guidelines into practice: a review of implementation. J. Am. Soc. Hypertens. 5:197-207
63. Hyman DJ, Pavlik VN. 2000. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch. Intern. Med. 160:2281-86
64. Foster JA, Yawn BP,Maziar A, JenkinsT,Rennard SI, Casebeer L. 2007. EnhancingCOPDmanagement in primary care settings. MedGenMed 9:24
65. Barth JH, Misra S, Aakre KM, Langlois MR, Watine J, et al. 2015. Why are clinical practice guidelines not followed Clin. Chem. Lab. Med. 54:1133-39
66. el-Kebbi IM, Ziemer DC, Gallina DL, Dunbar V, Phillips LS. 1999. Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care 22:1617-20
67. Bramlage P, Thoenes M, Kirch W, Lenfant C. 2007. Clinical practice and recent recommendations in hypertension management-reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr. Med. Res. Opin. 23:783-91
68. Steinman MA, Fischer MA, Shlipak MG, Bosworth HB, Oddone EZ, et al. 2004. Clinician awareness of adherence to hypertension guidelines. Am. J. Med. 117:747-54
69. Miller WR, Rollnick S. 2012. Motivational Interviewing: Helping People Change. New York: Guilford Press
70. Bandura A. 1986. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall, Inc.
71. Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. 2012. Barriers to adherence to COPD guidelines among primary care providers. Respir. Med. 106:374-81
72. Davis D, Galbraith R. 2009. Continuing medical education effect on practice performance: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest 135(Suppl.):42S-48S
73. Mostofian F, Ruban C, Simunovic N, Bhandari M. 2015. Changing physician behavior: What works Am. J. Manag. Care 21:75-84
74. Yen BM. 2006. Engaging physicians to change practice. J. Clin. Outcomes Manag. 13:103-10
75. Garg AX,AdhikariNKJ,McDonald H, Rosas-ArellanoMP, Devereaux PJ, et al. 2005. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 293:1223-38
76. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. 2005. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 330:765
77. Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR. 2011. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst. Rev. 2011:CD009255
78. Davis DA, Taylor-Vaisey A. 1997. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157:408-16
79. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. 2006. Does telling people what they have been doing change what they do A systematic review of the effects of audit and feedback. Qual. Saf. Health Care 15:433-36
80. Kazdin AE. 2012. Behavior Modification in Applied Settings. Long Grove, IL: Waveland Press
81. Deci EL, Ryan RM. 2002. Handbook of Self-Determination Research. Rochester, NY: Univ. Rochester Press
82. Rollnick S, Miller WR, Butler CC, Aloia MS. 2008. Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York: Guilford Press
83. Barratt A. 2008. Evidence based medicine and shared decision making: the challenge of getting both evidence and preferences into health care. Patient Educ. Couns. 73:407-12
84. Joosten EAG, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ. 2008. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother. Psychosom. 77:219-26
85. Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, et al. 2010. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma.Am. J. Respir. Crit.CareMed. 181:566-77
86. Rogers EM. 1995. Lessons for guidelines from the diffusion of innovations. Joint Comm. J. Qual. Improv. 21:324-28
87. Grilli R, Lomas J. 1994. Evaluating the message: the relationship between compliance rate and the subject of a practice guideline. Med. Care 32:202-13
88. Guidel. Int. Netw. 2016. About G-I-N: Introduction. Perthshire, Scotl.: Guidel. Int. Netw. http://www. g-i-n.net/about-g-i-n/introduction
89. Ollenschläger G, Marshall C, Qureshi S, Rosenbrand K, Burgers J, et al. 2004. Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual. Saf. Health Care 13:455-60
90. Watson M, Gunnell D, Peters T, Brookes S, Sharp D. 2001. Guidelines and educational outreach visits from community pharmacists to improve prescribing in general practice: a randomised controlled trial. J. Health Serv. Res. Policy 6:207-13
91. Giguère A, Légaré F, Grimshaw J, Turcotte S, Fiander M, et al. 2012. Printed educational materials: Effects on professional practice and healthcare outcomes. Cochrane Database Syst. Rev. 2012:CD004398
92. Majumdar SR,Tsuyuki RT,McAlister FA. 2007. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am. Heart J. 153:22.e1-8
93. FlodgrenG, Parmelli E, Doumit G, GattellariM,O'Brien MA, et al. 2011. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev. 2011:CD000125
94. Mehler PS, Krantz MJ, Lundgren RA, Estacio RO, MacKenzie TD, et al. 2005. Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention. Am. J. Med. 118:1414.e13-19
95. O'BrienMA, Rogers S, JamtvedtG,Oxman AD, Odgaard-Jensen J, et al. 2007. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev. 2007:CD000409
96. Brown R, Bratton SL, Cabana MD, Kaciroti N, Clark NM. 2004. Physician asthma education program improves outcomes for children of low-income families. Chest 126:369-74
97. Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O'Brien MA, et al. 2009. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev. 2009:CD003030
98. Foster JM, Hoskins G, Smith B, Lee AJ, Price D, Pinnock H. 2007. Practice development plans to improve the primary care management of acute asthma: randomised controlled trial. BMC Fam. Pract. 8:23
99. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, et al. 2012. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst. Rev. 2012:CD000259
100. Magruder-Habib K, Zung WW, Feussner JR. 1990. Improving physicians' recognition and treatment of depression in general medical care: results from a randomized clinical trial. Med. Care 28:239-50
101. Hemens BJ, Holbrook A, Tonkin M, Mackay JA, Weise-Kelly L, et al. 2011. Computerized clinical decision support systems for drug prescribing andmanagement: a decision-maker-researcher partnership systematic review. Implementation Sci. 6:89
102. Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, et al. 2013. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ 346:f657
103. Ziemer DC, Doyle JP, Barnes CS, Branch WT Jr., Cook CB, et al. 2006. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch. Intern. Med. 166:507-13
104. Medves J, Godfrey C, Turner C, Paterson M, Harrison M, et al. 2010. Systematic review of practice guideline dissemination and implementation strategies for healthcare teams and team-based practice. Int. J. Evid.-Based Healthc. 8:79-89
105. FeldmanRD, Zou GY, VandervoortMK, Wong CJ,Nelson SA, Feagan BG. 2009. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 53:646-53
106. Fairbrother G, Hanson KL, Friedman S, Butts GC. 1999. The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates. Am. J. Public Health 89:171-75
107. Scales DC, Dainty K, Hales B, Pinto R, Fowler RA, et al. 2011. A multifaceted intervention for quality improvement in a network of intensive care units: a cluster randomized trial. JAMA 305:363-72
108. Beck AT, Rush AJ, Shaw BF, Emery G. 1979. Cognitive Therapy of Depression. New York: Guilford Press
109. Janz NK, Becker MH. 1984. The health belief model: a decade later. Health Educ. Behav. 11:1-47
110. Prochaska JO, VelicerWF. 1997. The transtheoretical model of health behavior change. Am. J. Health Promot. 12:38-48
111. Ajzen I. 1991. The theory of planned behavior. Organ. Behav. Hum. Decis. Process. 50:179-211
112. Veazie PJ, Qian F. 2011. A role for regulatory focus in explaining and combating clinical inertia. J. Eval. Clin. Pract. 17:1147-52